We herein wondered whether high ZEB1/TWIST1 expression may be associated with the resistance to MAPKi in melanoma, with the final aim of testing whether targeting these factors in combination with MAPKi could prevent the emergence of resistance. The gene discussed is ZEB1; the disease is melanoma.